SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Maki, MD, PhD
University of Pennsylvania
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope National Medical Center
Duarte, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Sarcoma Oncology Research Center
Santa Monica, California, United States
- Stanford University
Stanford, California, United States
- Mayo Clinic - Florida
Jacksonville, Florida, United States
- H. Lee Moffitt
Tampa, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- Dana Farber/partners Cancer Care
Boston, Massachusetts, United States
- Mayo Clinic - Minnesota
Rochester, Minnesota, United States
- Carolinas Healthcare System
Charlotte, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- Ohio State University
Columbus, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Vanderbilt University
Nashville, Tennessee, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2014
- Primary completion
- 31 May 2022
- Completion
- 31 May 2022
- Last update posted
- 7 Nov 2023
- Registered enrollment
- 131
- Registry id
- NCT02048371
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.